Articles On Neuren Pharmaceuticals (ASX:NEU)

Highlights Broad market recovery led by mining, technology and healthcare shares Several ASX listed companies draw attention during the rebound Energy and consumer staples sectors move in the opposite direction Austral...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a decisive relief rally this Tuesday, delivering some welcome respite for investors after yesterday's horror-show start to the week. By the time trading wrapped up today, the ASX 200 had gained a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

ASX health sector flat for the week, while the S&P/ASX 200 falls xx% as Middle East conflict takes a toll on global markets LTR Pharma completes recruitment for a phase II pharmacokinetic clinical study of erectile dysfunction treatmen...

The Australian share market has traditionally delivered a return in the region of 10% per annum. While that is a fantastic return, it pales in comparison to the potential return on offer with the ASX 200 stock in this article. That's becaus...

Shares in Neuren Pharmaceuticals Ltd (ASX: NEU) have been under pressure in the past few months, so it's a good time to take a step back and see what the experts think about the way forward. The analyst team at Macquarie have an outperf...

ASX healthcare sector falls 13.31% in February as benchmark ASX 200 up 4% Blood products and vaccines giant CSL weighed heavily on sector down 19.1% in February Rhythm Biosciences up 48% in February to be sector’s biggest gainer for the mo...

The S&P/ASX 200 Index (ASX: XJO) is having a disappointing session on Tuesday. In afternoon trade, the benchmark index is down 1.2% to 9,088.9 points. Four ASX shares that are falling more than most today are listed below. Here's why...

Highlights• Cryosite reports stronger revenue and profit across storage divisions.• Neuren addresses European regulatory setback on Rett syndrome drug.• Entropy advances psychedelic-based binge eating disorder trial. Cryosite, Vitrafy,...

ASX stalwart Cryosite and newbie Vitrafy are having their day in the sun Neuren won’t take European knock-back lying down Entropy beds down its first cohort in its groundbreaking psychedelics trial   Investors are warming to the ASX-liste...

Highlights Market momentum cools after record-breaking rally Resources and asset managers dominate early trade moves Global tensions and commodities shape market direction The ASX 200 cooled after record highs as coal...

Neuren Pharmaceuticals Ltd (ASX: NEU) shares are under pressure on Tuesday. In morning trade, the ASX 200 stock is down over 6% to $12.89. Why is this ASX 200 stock under pressure? This morning, Neuren advised that its partner, Acadia Pharm...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

It was a stunning finish to a stunning trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Friday. After a record-breaking week of new record highs, investors decided to give the share market one more before headi...

Shares in Neuren Pharmaceuticals Ltd (ASX: NEU) are slightly lower on Friday after the company released its full-year results for 2025. In early afternoon trade, the Neuren share price is down 0.37% to $13.39. Let's take a closer look...

The Alcoa Corporation CDI (ASX: AAI) share price is in focus as the company announces a quarterly dividend of US 10 cents per CDI, payable on 26 March 2026, with a record date of 10 March. What did Alcoa report? Quarterly dividend of US 10...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is in focus after the company posted a 15% rise in 2025 DAYBUE royalties to A$65 million and a profit after tax of A$30 million. What did Neuren Pharmaceuticals report? 2025 royalty inc...

The Mesoblast Ltd (ASX: MSB) share price is focus today after the company reported a surge in revenue to US$51.3 million, thanks to the successful commercial launch of Ryoncil® in the US. What did Mesoblast report? Total revenue jumped to...

The Harvey Norman Holdings Ltd (ASX: HVN) share price is in focus today after the company posted a double digit uplift in profit before tax and raised its interim dividend for the half-year ended 31 December 2025. What did Harvey Norman rep...

The TPG Telecom Ltd (ASX: TPG) share price is in focus today after the company reported a 4.2% rise in mobile service revenue and an 18.4% jump in EBITDA for 2025, underpinned by its strongest mobile subscriber growth since 2022. What did T...

The Virgin Australia Holdings Ltd (ASX: VGN) share price is in focus after the airline reported a 11.7% lift in underlying EBIT for the first half of FY26, with underlying NPAT up 20.7% to $279 million despite ongoing industry cost pressure...

The WAM Capital Ltd (ASX: WAM) share price is in focus today after the company reported half-year profit of $24.1 million, an 83.9% decrease from the prior period, and declared an interim dividend of 7.75 cents per share, partially franked...

The Coles Group Ltd (ASX: COL) share price is in focus today after the supermarket giant reported a 2.5% rise in group sales revenue to $23.6 billion and a strong 12.5% lift in net profit (excluding significant items), with continued moment...

The Block (ASX: XYZ) share price is in focus today after the company released its results for the fourth quarter and full year ended 31 December 2025, reporting gross profit growth of 24% over the quarter and a significant 33% rise in Cash...

The PEXA Group Ltd (ASX: PXA) share price is in focus today after the company reported first-half FY26 revenue of $215.3 million, up 10% year-on-year, and Group NPAT of $15.4 million, turning around a prior loss. What did PEXA Group report?...

The Summerset Group Holdings Ltd (ASX: SNZ) share price is in focus after the company delivered a record underlying profit of NZ$234.2 million for the 2025 full year, up 13% on FY24, while total revenue climbed 13% to NZ$361.8 million. What...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is pushing higher today after the company released a fresh update to the market. At the time of writing, the Neuren share price is up 6.37% to $13.52. Let's take a closer look at w...

The Capricorn Metals Ltd (ASX: CCM) share price is in focus today after the company posted record first-half results, including a maiden 5 cents per share fully franked interim dividend. What did Capricorn Metals report? Sales revenue up 6...

The Worley Ltd (ASX: WOR) share price is in focus today as the company reported half-year 2026 results, highlighting 5.4% revenue growth to $6.31 billion and a steady underlying EBITA at $377 million, supported by strong project bookings an...

Neuren Pharmaceuticals Ltd (ASX: NEU) share price trading has been temporarily paused, pending a further announcement from the company, according to today's ASX market release. What did Neuren Pharmaceuticals report? Trading in Neuren Phar...

These 2 ASX healthcare shares have had an ordinary start to 2026. Telix Pharmaceuticals Ltd (ASX: TLX) and Neuren Pharmaceuticals Ltd (ASX: NEU) shares have lost 21% and 31% respectively this year so far. However, both ASX healthcare...

Rare diseases have become an increasingly attractive target for pharmaceutical companies  Canaccord’s Dr Shane Storey says there are strong incentives for companies to develop therapies for rare diseases Various ASX companies are focusing...

Neuren Pharmaceuticals Ltd (ASX: NEU) shares are trading slightly lower on Thursday afternoon. The move follows an announcement released after market close yesterday. At the time of writing, the Neuren share price is down 0.60% to $13.35...

The Northern Star Resources Ltd (ASX: NST) share price is in focus today after the gold miner reported NPAT of $714 million, up 41% from last year, and declared a fully franked interim dividend of 25 cents per share. What did Northern Star...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets took a breather, trading flat to slightly down on a higher than expected...

The Insurance Australia Group Ltd (ASX: IAG) share price is in focus today after the insurance giant posted a 23% jump in revenue to $11.14 billion, while net profit after tax (NPAT) fell 35.1% to $505 million for the half year ended 31 Dec...

The ANZ Group Holdings Ltd (ASX: ANZ) share price is in focus as the bank posted a first-quarter cash profit of $1.94 billion and a statutory profit of $1.87 billion. Cash profit jumped 75% compared to the second-half 2025 quarterly average...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) had a strong session and raced higher. The benchmark index rose 1.65% to 9,014.8 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200 set f...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is in focus today after the company announced a new on-market share buy-back program of up to 5% of its shares, supported by a strong cash position from its DAYBUE® franchise. What did...

ASX investors like shares and exchange-traded funds (ETFs) that pay out dividends on a monthly basis. Here on the ASX, it is the norm to pay out just two dividends per year. That is rather unusual by international standards, where quarterly...

Highlights Australian biotechnology companies reported regulatory and clinical updates. Trial modifications and site openings shaped sector activity. All Ordinaries classification reflects structured market participation....

The Challenger Ltd (ASX: CGF) share price is in focus today after the company confirmed it's in advanced talks to jointly acquire Pepper Money Ltd (ASX: PPM) alongside the Pepper Group. Challenger emphasised the potential acquisition would...

Are you hunting market-beating returns for your portfolio? If you are, then it could be worth considering the ASX 200 shares in this article. They have just been named as buys and tipped to rise very strongly from current levels. Here's wha...

Turning 45 can feel like a financial crossroads. For many Australians, it is the point where retirement stops being an abstract idea and starts to feel tangible. There's still time on your side, but not so much that progress can be left to...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is in focus today after the company announced its Koala Phase 3 clinical trial of NNZ-2591 for Phelan-McDermid syndrome (PMS) has dosed its first patient, marking a key milestone as the...

The Charter Hall Retail REIT (ASX: CQR) share price is in focus today after the group reported first half FY26 operating earnings of $75.6 million, up 3.4%, and a statutory profit of $240.7 million. What did Charter Hall Retail REIT report?...

The News Corporation (ASX: NWS) share price is on the move today after the company reported second quarter fiscal 2026 revenues of $2.36 billion, up 6% year over year, and a 9% lift in Total Segment EBITDA to $521 million. What did News Cor...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets fell again, led by Technology stocks, again, with silver crashing -15% an...

The REA Group Ltd (ASX: REA) share price is in focus today after Australia's top property platform delivered half-year revenue of $916 million, up 5% year-on-year, and lifted its net profit from core operations by 9% to $341 million. What d...

The Rio Tinto Ltd (ASX: RIO) share price is in focus today after the company confirmed it will not proceed with a possible merger or business combination with Glencore. Management stated the decision was driven by a focus on long-term value...